The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Recognition of Double-stranded RNA by Human Toll-like Receptor 3 and Downstream Receptor Signaling Requires Multimerization and an Acidic pH
Abstract
Studies involving Toll-like receptor 3 (TLR3)-deficient mice suggest that this receptor binds double-stranded RNA. In the present study, we analyzed ligand/receptor interactions and receptor-proximal events leading to TLR3 activation. The mutagenesis approach showed that certain cysteine residues and glycosylation in TLR3 amino-terminal leucine-rich repeats were necessary for ligand-induced signaling. Furthermore, inactive mutants had a dominant negative effect, suggesting that the signaling module is a multimer. We constructed a chimeric molecule fusing the amino-terminal ectodomain of TLR3 to the transmembrane and carboxyl terminal domains of CD32a containing an immunoreceptor tyrosine-based motif. Expression of TLR3-CD32 in HEK293T cells and the myeloid cell line U937 resulted in surface localization of the receptor, whereas the nonrecombinant molecule was intracellularly localized. The synthetic double-stranded RNAs poly(I-C) and poly(A-U) induced calcium mobilization in a TLR3-CD32 stably transfected U937 clone but not in control cells transfected with other constructs. An anti-TLR3 antibody also induced Ca(2+) flux but only when cross-linked by a secondary anti-immunoglobulin antibody, confirming that multimerization by the ligand is a requirement for signaling. The inhibitors of lysosome maturation, bafilomycin and chloroquine, inhibited the poly(I-C)-induced biological response in immune cells, showing that TLR3 interacted with its ligand in acidic subcellular compart…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In phagocytic cells, deacidification of endosomes using chloroquine reduces endosomal toll-like receptor response.
“In phagocytic cells, the deacidification of endosomes using pharmacological inhibitors like chloroquine has been shown to reduce endosomal toll-like receptor (TLR) response (de Bouteiller et al., 2005; Fox, 2019; Kuznik et al., 2011; Wozniacka et al., 2006; Yang et al., 2016)”
From NHE6 depletion corrects ApoE4-mediated synaptic impairments and reduces amyloid plaque load (2021) · cites this paper as de Bouteiller et al., 2005
Citations
Cites
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
Toll-like receptors: critical proteins linking innate and acquired immunity
Akira, S., Takeda, K., & Kaisho, T. (2001) · Nature Immunology · doi:10.1038/90609 · Cited by 4,777
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444
Roles of N-Linked Glycans in the Endoplasmic Reticulum
Helenius, A., & Aebi, M. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073752 · Cited by 2,037
mRNA is an endogenous ligand for toll-like receptor 3
Karikó, K., Ni, H., Capodici, J., Lamphier, M., & Weissman, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310175200 · Cited by 1,062
Binding of the Drosophila cytokine Spätzle to Toll is direct and establishes signaling
Weber, A. N. R., Tauszig-Delamasure, S., Hoffmann, J. A., Lelièvre, E., Gascan, H., Ray, K. P., Morse, M. A., Imler, J.-L., & Gay, N. J. (2003) · Nature Immunology · doi:10.1038/ni955 · Cited by 469
Flagged first, then by citations
Research works printed but not linked: 64
- Medzhitov, 2000, Trends Microbiol., 8, 452, 10.1016/S0966-842X(00)01845-X · DOI
- Takeda, 2003, Annu. Rev. Immunol., 21, 335, 10.1146/annurev.immunol.21.120601.141126 · DOI · Paper page
- Kaisho, 2003, Curr. Mol. Med., 3, 373, 10.2174/1566524033479726 · DOI
- Beutler, 2004, Nature., 430, 257, 10.1038/nature02761 · DOI
- Beg, 2002, Trends Immunol., 23, 509, 10.1016/S1471-4906(02)02317-7 · DOI
- Leadbetter, 2002, Nature., 416, 603, 10.1038/416603a · DOI
- Wang, 2004, Nat. Med., 10, 1366, 10.1038/nm1140 · DOI
- Aksoy, 2005, J. Biol. Chem., 280, 277, 10.1074/jbc.M411223200 · DOI
- O'Neill, 2003, Trends Immunol., 24, 286, 10.1016/S1471-4906(03)00115-7 · DOI
- Yamamoto, 2003, Nat. Immunol., 4, 1144, 10.1038/ni986 · DOI
- Yamamoto, 2002, J. Immunol., 169, 6668, 10.4049/jimmunol.169.12.6668 · DOI
- Hoebe, 2004, J. Endotoxin Res., 10, 130, 10.1177/09680519040100021001 · DOI
- Yamamoto, 2003, Science., 301, 640, 10.1126/science.1087262 · DOI
- Fitzgerald, 2003, Nat. Immunol., 4, 491, 10.1038/ni921 · DOI
- Sarkar, 2004, Nat. Struct. Mol. Biol., 11, 1060, 10.1038/nsmb847 · DOI
- Mukhopadhyay, 2004, Immunology., 112, 521, 10.1111/j.1365-2567.2004.01941.x · DOI
- Ozinsky, 2000, Proc. Natl. Acad. Sci. U. S. A., 97, 13766, 10.1073/pnas.250476497 · DOI
- Sandor, 2003, J. Cell Biol., 162, 1099, 10.1083/jcb.200304093 · DOI
- Medzhitov, 1997, Nature., 388, 394, 10.1038/41131 · DOI
- Ahmad-Nejad, 2002, Eur. J. Immunol., 32, 1958, 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U · DOI
- Heil, 2003, Eur. J. Immunol., 33, 2987, 10.1002/eji.200324238 · DOI
- Lee, 2003, Proc. Natl. Acad. Sci. U. S. A., 100, 6646, 10.1073/pnas.0631696100 · DOI
- Latz, 2004, Nat. Immunol., 5, 190, 10.1038/ni1028 · DOI
- Rutz, 2004, Eur. J. Immunol., 34, 2541, 10.1002/eji.200425218 · DOI
- Matsumoto, 2001, Uirusu., 51, 209, 10.2222/jsv.51.209 · DOI
- Matsumoto, 2002, Biochem. Biophys. Res. Commun., 293, 1364, 10.1016/S0006-291X(02)00380-7 · DOI
- Matsumoto, 2003, J. Immunol., 171, 3154, 10.4049/jimmunol.171.6.3154 · DOI
- Hasan, 2004, Biochem. Biophys. Res. Commun., 321, 124, 10.1016/j.bbrc.2004.06.134 · DOI
- Zhang, 2002, J. Biol. Chem., 277, 7059, 10.1074/jbc.M109537200 · DOI
- Daeron, 1997, Annu. Rev. Immunol., 15, 203, 10.1146/annurev.immunol.15.1.203 · DOI · Paper page
- Sallusto, 1994, J. Exp. Med., 179, 1109, 10.1084/jem.179.4.1109 · DOI · Paper page
- Choe, 2005, Science., 309, 581, 10.1126/science.1115253 · DOI
- Bell, 2005, Proc. Natl. Acad. Sci. U. S. A., 102, 10976, 10.1073/pnas.0505077102 · DOI
- Hasan, 2005, J. Biol. Chem., 280, 20620, 10.1074/jbc.M500877200 · DOI
- Odin, 1991, Science., 254, 1785, 10.1126/science.1837175 · DOI
- Shen, 1994, J. Immunol., 153, 5849, 10.4049/jimmunol.153.12.5849 · DOI
- Van den Herik-Oudijk, 1995, Blood., 86, 3302, 10.1182/blood.V86.9.3302.bloodjournal8693302 · DOI
- Weber, 2002, J. Immunol., 168, 5303, 10.4049/jimmunol.168.10.5303 · DOI
- da Silva Correia, 2002, J. Biol. Chem., 277, 1845, 10.1074/jbc.M109910200 · DOI
- Shi, 2004, J. Virol., 78, 5414, 10.1128/JVI.78.10.5414-5422.2004 · DOI
- Nishiya, 2004, J. Biol. Chem., 279, 19008, 10.1074/jbc.M311618200 · DOI
- Funami, 2004, Int. Immunol., 16, 1143, 10.1093/intimm/dxh115 · DOI
- Heil, 2004, Science., 303, 1526, 10.1126/science.1093620 · DOI · Paper page
- Wu, 2004, J. Biol. Chem., 279, 33071, 10.1074/jbc.M311662200 · DOI
- Lee, 2004, J. Biol. Chem., 279, 10564, 10.1074/jbc.M311564200 · DOI
- Hasan, 2005, J. Immunol., 174, 2942, 10.4049/jimmunol.174.5.2942 · DOI
- Sugimoto, 2001, Biochemistry., 40, 9396, 10.1021/bi010666l · DOI
- Leifer, 2004, J. Immunol., 173, 1179, 10.4049/jimmunol.173.2.1179 · DOI
- Kariko, 2004, J. Cereb. Blood Flow Metab., 24, 1288, 10.1097/01.WCB.0000145666.68576.71 · DOI
- Kariko, 2004, J. Immunol., 172, 6545, 10.4049/jimmunol.172.11.6545 · DOI
- Albert, 2004, Nat Rev. Immunol., 4, 223, 10.1038/nri11308 · DOI
- Gallucci, 1999, Nat. Med., 5, 1249, 10.1038/15200 · DOI
- Sauter, 2000, J. Exp. Med., 191, 423, 10.1084/jem.191.3.423 · DOI
- Basu, 2000, Int. Immunol., 12, 1539, 10.1093/intimm/12.11.1539 · DOI
- Salio, 2000, Eur. J. Immunol., 30, 705, 10.1002/1521-4141(200002)30:2<705::AID-IMMU705>3.0.CO;2-P · DOI
- Edelmann, 2004, Virology., 322, 231, 10.1016/j.virol.2004.01.033 · DOI
- Garoff, 2004, Virus Res., 106, 103, 10.1016/j.virusres.2004.08.008 · DOI
- Salonen, 2003, J. Virol., 77, 1691, 10.1128/JVI.77.3.1691-1702.2003 · DOI
- Sherer, 2003, Traffic., 4, 785, 10.1034/j.1600-0854.2003.00135.x · DOI
- Pelchen-Matthews, 2003, J. Cell Biol., 162, 443, 10.1083/jcb.200304008 · DOI
- Akula, 2003, J. Virol., 77, 7978, 10.1128/JVI.77.14.7978-7990.2003 · DOI
- Guillot, 2004, J. Biol. Chem., 279, 2712, 10.1074/jbc.M305790200 · DOI
- Tabeta, 2004, Proc. Natl. Acad. Sci. U. S. A., 101, 3516, 10.1073/pnas.0400525101 · DOI
- Schulz, 2005, Nature., 433, 887, 10.1038/nature03326 · DOI
Cited by
Sorted by citations
Toll-like Receptors and the Control of Immunity
Fitzgerald, K. A., & Kagan, J. C. (2020) · Cell · doi:10.1016/j.cell.2020.02.041 · Cited by 2,168
Structural Basis of Toll-Like Receptor 3 Signaling with Double-Stranded RNA
Liu, L., Botos, I., Wang, Y., Leonard, J. N., Shiloach, J., Segal, D. M., & Davies, D. R. (2008) · Science · doi:10.1126/science.1155406 · Cited by 733
DAMPs as mediators of sterile inflammation in aging-related pathologies
Feldman, N., Rotter-Maskowitz, A., & Okun, E. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.01.003 · Cited by 283
Nucleic acid‐sensing TLR s and autoimmunity: novel insights from structural and cell biology
Pelka, K., Shibata, T., Miyake, K., & Latz, E. (2016) · Immunological Reviews · doi:10.1111/imr.12375 · Cited by 110
RNA Mediated toll-like receptor stimulation in health and disease
Dalpke, A. H., & Helm, M. (2012) · RNA Biology · doi:10.4161/rna.20206 · Cited by 113
Extracellular RNA sensing by pattern recognition receptors
Tatematsu, M., Funami, K., Seya, T., & Matsumoto, M. (2018) · Journal of Innate Immunity · doi:10.1159/000494034 · Cited by 90
Toll-like receptor polymorphisms and age-related macular degeneration
Edwards, A. O., Chen, D., Fridley, B. L., James, K. M., Wu, Y., Abecasis, G., Swaroop, A., Othman, M., Branham, K., Iyengar, S. K., et al. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1378 · Cited by 84
Chandler, L., Yusuf, I., McClements, M., Barnard, A., MacLaren, R., & Xue, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144972 · Cited by 49
NHE6 depletion corrects ApoE4-mediated synaptic impairments and reduces amyloid plaque load
Pohlkamp, T., Xian, X., Wong, C. H., Durakoglugil, M. S., Werthmann, G. C., Saido, T. C., Evers, B. M., White, C. L., Connor, J., Hammer, R. E., et al. (2021) · eLife · doi:10.7554/elife.72034 · Cited by 46
Metadata
- Authors
- de Bouteiller, O., Merck, E., Hasan, U. A., Hubac, S., Benguigui, B., Trinchieri, G., Bates, E. E. M., & Caux, C.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-11
- Volume
- 280
- Issue
- 46
- Pages
- 38133-38145
- ISSN
- 0021-9258
- Cited by
- 220
- References
- 6
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review